Opus Genetics Inc.
XNAS:IRD 4:00:00 PM EDT
| Market Cap (Intraday) | 348.66M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $5.21 |
| 50-Day MA | $4.73 |
| 200-Day MA | $2.58 |
Opus Genetics Inc. Stock, XNAS:IRD
8 Davis Drive, Suite 220, Durham, North Carolina 27709
United States of America
Phone: +1.248.957.9024
Number of Employees: 14
Description
Opus Genetics, Inc. engages in the research and development of ophthalmic biopharmaceutical products. It focuses on developing and commercializing therapies for the treatment of several eye disorders. The company was founded by Mina Patel Soouch and Alan R. Meyer in February 2018 and is headquartered in Durham, NC.